Date: 2011-01-11
Type of information:
Compound: EB66® cell line for the manufacturing of a veterinary vaccine
Company: Vivalis (France) Merial
Therapeutic area: Veterinary medicine
Type agreement: licensing
Action mechanism:
Disease:
Details: The two companies have signed a new commercial license for the production of a veterinary vaccine using Vivalis' EB66® cell line in last December 2010.
Financial terms:
Latest news:
